Cargando…
Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study
The preventive efficacies and safety of Emblica Officinalis Gatertn (Amla), a most important and extensively studied plant in the traditional Indian Ayurvedic system of medicine, are presented. Eligible healthy adult subjects (n = 15) were randomized to receive either amla or placebo (500 mg per day...
Autores principales: | Kapoor, Mahendra Parkash, Suzuki, Koji, Derek, Timm, Ozeki, Makoto, Okubo, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926135/ https://www.ncbi.nlm.nih.gov/pubmed/31890983 http://dx.doi.org/10.1016/j.conctc.2019.100499 |
Ejemplares similares
-
Emblica officinalis (Amla) Ameliorates High-Fat Diet Induced Alteration of Cardiovascular Pathophysiology
por: Patil, Bheemshetty S., et al.
Publicado: (2019) -
Efficacy of crude extract of Emblica officinalis (amla) in arsenic-induced oxidative damage and apoptosis in splenocytes of mice
por: Singh, Manish Kumar, et al.
Publicado: (2014) -
Functional and Nutraceutical Significance of Amla (Phyllanthus emblica L.): A Review
por: Gul, Maryam, et al.
Publicado: (2022) -
Genome of Phyllanthus emblica: the medicinal plant Amla with super antioxidant properties
por: Mahajan, Shruti, et al.
Publicado: (2023) -
A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin
por: Gopa, Biswas, et al.
Publicado: (2012)